CA1113088A - PROCESS FOR THE PREPARATION OF THYMOSIN .alpha..SUB.1 AND AN ANALOGUE - Google Patents

PROCESS FOR THE PREPARATION OF THYMOSIN .alpha..SUB.1 AND AN ANALOGUE

Info

Publication number
CA1113088A
CA1113088A CA301,643A CA301643A CA1113088A CA 1113088 A CA1113088 A CA 1113088A CA 301643 A CA301643 A CA 301643A CA 1113088 A CA1113088 A CA 1113088A
Authority
CA
Canada
Prior art keywords
obzl
glu
bzl
lys
ala
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA301,643A
Other languages
English (en)
French (fr)
Inventor
Su-Sun Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/871,563 external-priority patent/US4116951A/en
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Priority to CA383,969A priority Critical patent/CA1123428A/en
Application granted granted Critical
Publication of CA1113088A publication Critical patent/CA1113088A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06086Dipeptides with the first amino acid being basic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/57581Thymosin; Related peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043Leu-amino acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CA301,643A 1977-04-22 1978-04-21 PROCESS FOR THE PREPARATION OF THYMOSIN .alpha..SUB.1 AND AN ANALOGUE Expired CA1113088A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA383,969A CA1123428A (en) 1977-04-22 1981-08-14 PROCESS FOR THE PREPARATION OF THYMOSIN .alpha..SUB.1 AND AN ANALOGUE

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US78989877A 1977-04-22 1977-04-22
US789,898 1977-04-22
US871,563 1978-01-23
US05/871,563 US4116951A (en) 1977-04-22 1978-01-23 [Asn2 ]-thymosin α1 and analogs thereof

Publications (1)

Publication Number Publication Date
CA1113088A true CA1113088A (en) 1981-11-24

Family

ID=27120967

Family Applications (1)

Application Number Title Priority Date Filing Date
CA301,643A Expired CA1113088A (en) 1977-04-22 1978-04-21 PROCESS FOR THE PREPARATION OF THYMOSIN .alpha..SUB.1 AND AN ANALOGUE

Country Status (18)

Country Link
JP (1) JPS53137914A (da)
AT (1) AT364470B (da)
CA (1) CA1113088A (da)
CH (3) CH641152A5 (da)
DE (1) DE2817082A1 (da)
DK (1) DK147918C (da)
ES (1) ES469016A1 (da)
FI (1) FI781241A (da)
FR (2) FR2401134A1 (da)
GB (1) GB1590668A (da)
GR (1) GR71886B (da)
HU (1) HU180783B (da)
IT (1) IT1113134B (da)
LU (1) LU79488A1 (da)
NL (1) NL7804364A (da)
NO (2) NO781404L (da)
PT (1) PT67937B (da)
SE (1) SE447262B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4116951A (en) * 1977-04-22 1978-09-26 Hoffmann-La Roche Inc. [Asn2 ]-thymosin α1 and analogs thereof
DE2919592A1 (de) * 1979-05-15 1981-01-15 Max Planck Gesellschaft Verfahren zur herstellung von thymosin- alpha 1 und derivaten davon
EP0033384B1 (de) * 1980-01-18 1984-02-15 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Thymosin-alpha-1-Fragmente enthaltende Arzneimittel mit immunstimulierender Wirkung, und Thymosin-alpha-1-Fragmente
US4339427A (en) * 1980-04-14 1982-07-13 Hoffmann-La Roche Inc. Radioimmunoassay of thymosinα
EP0056594B1 (de) * 1981-01-14 1984-09-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Thymosin-alpha-1-Fragmente enthaltende Arzneimittel mit immunregulierender Wirkung und Thymosin-alpha-1-Fragmente
CN1058500C (zh) * 1993-02-03 2000-11-15 施塞克龙药品公司 胸腺素α-1衍生物
US6262230B1 (en) * 1994-01-28 2001-07-17 Sciclone Pharmaceuticals Inc. Analogs of thymosin α1

Also Published As

Publication number Publication date
FR2401134B1 (da) 1983-09-30
DE2817082A1 (de) 1978-11-02
FI781241A (fi) 1978-10-23
FR2405926A1 (fr) 1979-05-11
DK169478A (da) 1978-10-23
GB1590668A (en) 1981-06-03
PT67937A (en) 1978-05-01
FR2405926B1 (da) 1983-09-09
NO148924B (no) 1983-10-03
SE7804612L (sv) 1978-12-20
NL7804364A (nl) 1978-10-24
PT67937B (en) 1980-04-07
IT1113134B (it) 1986-01-20
LU79488A1 (de) 1979-05-25
DK147918B (da) 1985-01-07
SE447262B (sv) 1986-11-03
HU180783B (en) 1983-04-29
CH641152A5 (en) 1984-02-15
CH641153A5 (en) 1984-02-15
FR2401134A1 (fr) 1979-03-23
JPS53137914A (en) 1978-12-01
GR71886B (da) 1983-08-04
NO148924C (no) 1984-01-11
DK147918C (da) 1985-08-19
AT364470B (de) 1981-10-27
CH640218A5 (en) 1983-12-30
NO781404L (no) 1978-10-24
ATA286178A (de) 1981-03-15
IT7822629A0 (it) 1978-04-21
NO821608L (no) 1978-10-24
ES469016A1 (es) 1980-01-01

Similar Documents

Publication Publication Date Title
US4148788A (en) Synthesis of thymosin α1
US4116951A (en) [Asn2 ]-thymosin α1 and analogs thereof
CA1182109A (en) Polypeptides, processes for their production, pharmaceutical compositions comprising said polypeptides and their use
FI92325B (fi) Menetelmä tymopentiinianalogien valmistamiseksi
US4490364A (en) CCK Agonists II
CA1267998A (en) Synthesis of hpgrf (somatocrinin) in liquid phase and intermediate peptides
CA1113088A (en) PROCESS FOR THE PREPARATION OF THYMOSIN .alpha..SUB.1 AND AN ANALOGUE
CA1267996A (en) Peptides which are active on the central nervous system and have an action on the cholinergic system
US4473555A (en) Nona- and dodecapeptides for augmenting natural killer cell activity
US3917578A (en) Process for producing somatostatin and intermediates
US4797469A (en) Synthesis of hGRF (Somatocrinin) in liquid phase and intermediate peptides
KR850000476B1 (ko) 펩티드의 제조방법
US5428129A (en) Peptides and processes for producing cyclic peptides
CA1094051A (en) Polypeptide having serum calcuim reducing activity
Shenbagamurthi et al. Biological activity and conformational isomerism in position 9 analogs of the des-1-tryptophan, 3. beta.-cyclohexylalanine-. alpha.-factor from Saccharomyces cerevisiae
US5091366A (en) Peptides having ANF activity
CA1113457A (en) Aminoethylglycine containing polypeptides
EP0132919B1 (en) Peptides
CA1123428A (en) PROCESS FOR THE PREPARATION OF THYMOSIN .alpha..SUB.1 AND AN ANALOGUE
KR840000054B1 (ko) 티모신 α₁의 제조방법
EP0292256A2 (en) Peptides having ANF activity
Wang et al. [Asn 2]-thymosin α 1 and analogs thereof
US4105652A (en) Synthesis of human β-endorphin
US4081530A (en) Extended chain derivatives of somatostatin
US20070111930A1 (en) Process for preparing vapreotide

Legal Events

Date Code Title Description
MKEX Expiry